Prot# 01-02-TL-375-022: A Phase III, Open-Label, Fixed-Dose Study to Determine the Safety of Long Term Administration of TAK-375 in Subjects with Chronic Insomnia

Project: Research project

Project Details

StatusFinished
Effective start/end date6/9/03 → 3/4/05

Funding

  • Covance Periapproval Services, Inc. (01-02-TL-375-022)
  • Takeda Pharmaceuticals U.S.A., Inc. (01-02-TL-375-022)
View all
View less